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Abstract 
 
New tools are needed to enable rapid detection, identification, and reporting of infectious viral and 
microbial pathogens in a wide variety of point-of-care applications that impact human and animal 
health. We report the design, construction, and characterization of a multiplexed platform for 
multiplexed analysis of disease-specific DNA sequences that utilizes a smartphone camera as the 
sensor in conjunction with a handheld “cradle” that interfaces the phone with a silicon-based 
microfluidic chip embedded within a credit card-sized cartridge. Utilizing specific nucleic acid 
sequences for four equine respiratory pathogens as representative examples, we demonstrate the 
ability of the system to utilize a single 15 µL droplet of test sample to perform selective 
positive/negative determination of target sequences, including integrated experimental controls, in 
approximately 30 minutes.  Our approach utilizes loop mediated isothermal amplification (LAMP) 
reagents pre-deposited into distinct lanes of the microfluidic chip, which, when exposed to target 
nucleic acid sequences from the test sample, generates fluorescent products that, when excited by 
appropriately selected light emitting diodes (LEDs) are visualized and automatically analyzed by 
a software application running on the smartphone microprocessor. The system achieves detection 
limits comparable to those obtained by laboratory-based methods and instruments. Assay 
information is combined with information from the cartridge and the patient to populate a cloud-
based database for epidemiological reporting of test results. 
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1. Introduction 
1.1. Equine Respiratory Tract infection  
1.1.1. Background 
Thoroughbred horse racing is an industry that churns out $4 billion per year. Thoroughbred 
racing stables and breeding farms are professionally run organizations and in many ways are 
similar to commercial food animal herd producers in terms of their sophisticated record 
keeping, veterinary care, understanding of genetics, and need to rapidly diagnose an 
infectious disease that can injure, kill, or render unsafe large numbers of high-value animals 
though an outbreak. Respiratory disease is common in horses and difficult to diagnose using 
the current methods available to practicing veterinarians. Currently there is little to no 
monitoring of the health of horses even though they are the most valuable of livestock. Some 
respiratory conditions such as Inflammatory Airway Disease (IAD) and Interstitial Lung 
Disease are poorly understood [1] although animals are predisposed to these conditions by 
viral and bacterial infections [2], which occur worldwide [3]. 
 
1.1.2. Current diagnostic pathway 
Respiratory tract infection is a major cause of mortality and morbidity in horse populations. 
[4] The effect of infectious respiratory tract infection is magnified in race tracks where entire 
horse population needs to be quarantined due to long diagnostic turnaround times and 
inadequate on-site intervention strategies. There have been a significant increase in EHV-1 
outbreaks in the US in recent years, which have led to millions of dollars in costs. Current 
methods of to evaluate horse respiratory tract include invasive techniques such as endoscopic 
examination, or imaging techniques such as ultrasonogram. [5] Other diagnostic approach 
includes cytology and a bacterial culture of the of the horse respiratory secretion. These 
techniques are not suitable for a field-tailored application where early diagnosis of sick 
horses is required for quarantine. Samples for must first be sent to a reference lab, and the 
turnaround times for test results is usually in days by which time the entire racetrack might 
have been affected. Furthermore, these tests themselves are not sensitive enough to 
distinguish between closely related strains of the equine respiratory tract infection such as 
the Equine Herpesvirus subtypes. Diagnosing the correct Equine Herpesvirus subtype is 
particularly important since the equine herpesvirus 1 have been associated with neurological 
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disorders and high rates of mortality among horses. The distinction between the two strains 
of the Equine Herpesvirus can be determined by highly specific and sensitive nucleic acid 
amplification tests such as PCR. Infections caused by Equine viral rhinopneumonitis, it is 
difficult to clinically differentiate from equine influenza, equine viral arteritis, or other 
equine respiratory infections solely on the basis of clinical signs. Definitive diagnosis is 
determined by PCR by extracting nucleic acid from the horse respiratory secrection 
(nasopharyngeal swab). [2] Strangles is another very common equine respiratory tract 
infection caused by Streptococcus Equi Subsp. Equi (S. Equi) or Streptococcus Equi Subsp. 
Zooepidemicus (S.Zooep). Nucleic acid amplification tests, such as PCR, has been used to 
distinguish between these two closely related strains responsible for strangles.  
1.2. Nucleic acid amplification tests (NAATs) in point-of-care testing 
Polymerase Chain Reaction (PCR) is the most commonly used technique for the detection 
of nucleic acid target from any bacterial or viral pathogenic source [6-8].  PCR enables 
sequence-specific concentration amplification of infectious disease DNA through a series of 
thermally cycled chemical reactions between a set of enzymes, a prepared test sample (of 
DNA extracted from a pathogen-containing bodily fluid), and disease-specific “primer” 
molecules.  PCR primers for detection of every common human and animal infectious 
disease have been identified, and may be inexpensively synthesized through readily available 
commercial sources. Conventional PCR amplification requires expensive laboratory-based 
instruments that are operated by technicians and housed in central facilities, although there 
have been strong efforts aimed at miniaturization of PCR for translation closer to the point 
of care through the engineering of systems integrated into a small chip or cartridge [6, 8-36]. 
Many of these efforts have been aimed at accelerating the thermal cycling process through 
reduction in the liquid volume  [17, 21, 26, 27, 30, 32, 35, 37-40], while others have explored 
various modalities for sensing the presence of the amplified product using biosensors [41-
45].  Due to the cost and complexity of implementing thermal cycling (generally between 95 
°C (denaturation), 72 °C (extension), and 68 °C (annealing) with ~30-40 cycles), various 
isothermal nucleic acid amplification methods have been proposed and demonstrated with 
comparable sensitivity to PCR [46-48], but with a requirement to more fully customize and 
validate the primer sequences. Of these, loop-mediated Isothermal amplification (LAMP) 
has emerged as a compelling approach for portable applications [49-51], particularly due to 
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its ability to utilize unprocessed or minimally processed test samples without inhibition of 
the reaction. [52] As the name suggests, LAMP reactions take place at a single incubation 
temperature of 65C. This eliminates the use of any complex instruments required for thermal 
cycling. LAMP reactions can take place on a simple heating block or even a oven maintained 
at 65C.  
 
1.3.  Point-of-care testing for the detection of Equine respiratory pathogens 
A key characteristic for a successful system for detection and reporting of infectious disease 
is speed.  Particularly for point-of-care scenarios, where the clinician is testing a patient at a 
remote clinic, a farm, or a racetrack, the need to send samples to a central laboratory, to wait 
for the test to be performed, and to wait for the results to be reported, results in an enormous 
waste of opportunity to determine if aggressive treatment or quarantine is needed before the 
disease spreads further.  The ability to rapidly share the results of positive and negative tests 
can revolutionize the manner in which infectious diseases are managed.  Therefore, it is of 
paramount importance for the test to be performed at the same location as the patient, so 
action can be taken within the same day that the sample is gathered. A second key 
characteristic for a POC test is the ability to simultaneously test for the presence of more than 
one pathogen with a single test protocol, which lowers cost, saves time/effort, and allows for 
a panel of pathogens, which may cause similar symptoms, to be identified (Equine influenza 
vs Equine Arteritis virus).  
 
 1.4. Smartphone-based point-of-care setup 
A key feature of a POC setup is the use of inexpensive, easily available, and ready 
to fabricate detection systems. [53-56]. Due to the rapid development of 
computational, communication, and sensing capabilities of smartphones since the 
introduction of the iPhone in 2007, these devices have become similar to personal 
computers with integrated cameras, geolocation capabilities, and access to cloud 
services.  The widespread use of smartphone makes it a very attractive candidate for 
fluorescence or optical detection modalities. Recent examples include attachments 
that enable smartphones to serve as stethoscopes [58], ultrasound probes [59], 
microscopes [60], fluorescent microscopes [61, 62], label-free biosensor detection 
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instruments [63, 64], fluorimeters [65], and colorimetric assay readers [66]. Portable 
detection systems for infectious disease are already recognized as a likely extension 
of mobile technology [49, 67-72], and PCR or LAMP mobile sensing platform that 
is integrated with a smartphone and a smart service system for reporting and sharing 
results with a network of users is highly desirable. 
 1.5. Our technique 
In this work, we combine the sensitivity and specificity of nucleic acid amplification assays 
for the detection of a panel of equine respiratory tract pathogens with a smartphone-based 
detection system. While our ultimate goal is the diagnosis and mobile reporting of human 
infectious diseases, we initially focus specifically upon equine respiratory infections due 
to their economic importance to the horse racing industry, similarity to the tests that would 
have an impact upon the food animal industry, and the strong need for a service system 
that can inform networks of field veterinarians. Our work involves the development of a 
microfluidic approach for identifying the presence of specific nucleic acid sequences from 
the pathogens of equine respiratory infections using a portable detection system integrated 
as a disposable cartridge that can be read by a conventional smartphone in conjunction with 
a custom-designed cradle. Capable of simultaneously performing 10 parallel isothermal 
amplifications (with two utilized for experimental controls and eight for pathogen-specific 
DNA detection assays), the system can detect target DNA sequences from more than one 
pathogen with a single test protocol, and interface with a smartphone app that 
communicates with a cloud-based service for the immediate reporting of the location, time, 
identity, and results (positive and negative) of the detection. In this paper, four LAMP-
based assays have been developed for the detection of four important equine respiratory 
infectious pathogens:  streptococcus equi (S. Equi), strangles (streptococcus 
zooepidemicus, abbreviated as S. Zoo), equine herpesvirus type 1 and type 4 (EHV-1 and 
EHV-4). The smartphone-based detection demonstrates the same detection limits and 
sensitivity as LAMP reactions performed on commercially available laboratory-based 
systems, and is capable of identifying the specific nucleic acid sequences of pathogens for 
both single-infection and co-infection scenarios. To our knowledge, a smartphone-based 
nucleic acid testing approach for the diagnosis of veterinary infectious diseases has not 
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been reported in previous literature.  This platform can be easily extended for the 
simultaneous detection of any closely-related human pathogens.  
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2. Literature review 
In this section, we will discuss various competing point-of-care techniques, and details about loop-
mediated isothermal amplification and its use in our techniques.  
2.1. Current Nucleic Acid Amplification based miniaturized setups 
State-of-the-art miniaturized systems that perform DNA amplification reactions can be classified 
as: small thermocyclers with integrated photodiodes [11, 83], microfluidic systems with 
customized optics for automated and multiplexed experiments [49, 84, 85], and systems based on 
electrochemical principles that achieve miniaturization by removing optical elements [86, 87]. 
Small thermocyclers like ‘Palm PCR’ [83] let the user perform the reaction in a pocket-size device 
but all the sample preparation is still performed by the user and there are no multiplexing 
capabilities. The microfluidic ‘FilmArray’ [84] system is highly automated and considerably 
reduces sample preparation and handling. However, the instrument size and complexity results in 
an expensive bench-top system that is not suitable for portable applications. Electrochemical-based 
systems like the one demonstrated by DNA Electronics [86]  monitors variables like pH change or 
secondary redox reactions to assess DNA amplification without optical elements. However, these 
alternatives require the compartmentalization of reactions since the monitoring variables are not 
specific to the target complicating assay multiplexing. 
 
In general, miniaturized DNA amplification systems seek to minimize footprint, automate 
processes, and reduce cost without losing sensitivity and specificity of the assay [88]. Additionally, 
especially for infectious disease detection, it is desirable to have multiplexed assays that enable 
the screening of multiple agents in a single assay and it is important to create data networks to 
quickly analyze and share information to contain outbreaks. The devices referenced above fulfill 
some of these characteristics, but there is no system with all the desired features. In the following 
sections, we will highlight how our developed device aims to fulfill each of these characteristics.  
2.2.  Loop mediated isothermal amplification (LAMP) 
 
LAMP is a novel nucleic acid amplification method that was first reported by Notomi et al in 
2000.[52] It is a one-step amplification reaction that amplifies target nucleic acid sequence 
with high specificity and sensitivity under isothermal conditions and has sensitivity 
comparable to traditional PCR. The LAMP reaction can also be used for detection of viral 
7 
 
RNA or mRNA by adding heat-stable reverse transcriptase to the reaction. This section will 
discuss the mechanism, primer design and key features of RT-LAMP reaction. 
 
This technique relies on auto-cycling strand displacement DNA synthesis that is performed by 
a strand displacement DNA polymerase with high activity and a set of two specially designed 
inner and two outer primers. These sets of primers recognize a total of six distinct sequences 
on the target DNA. At the LAMP reaction temperature (60 − 65 ◦C) double stranded DNA is 
in a ‘dynamic equilibrium’ allowing primers to anneal to the complimentary sequence in the 
target double stranded DNA and thereby triggering the polymerase to make initial elongations. 
Initially, all four primers are used, but later during the cycling reaction only the inner primers 
are used for strand displacement DNA synthesis. The inner primers are called the forward inner 
primer (FIP) and the backward inner primer (BIP), respectively, and each contains two distinct 
sequences corresponding to the sense and antisense sequences of the target DNA, one for 
priming in the first stage and the other for self-priming in later stages. During the initial 
elongation, the polymerase releases a single stranded DNA that is then used for further 
downstream reactions of making loop structures which serves as the element for downstream 
amplification. 
 In the subsequent LAMP cycling one inner primer hybridizes to the loop on the 
aforementioned product and initiates the displacement DNA synthesis, yielding the original 
stem–loop DNA in addition to a new stem–loop DNA with a stem twice as long. This cycling 
reaction continues with accumulation of 10^9 copies of target in less than an hour. The reaction 
will stop when concentration of free deoxyribonucleotides (dNTPs) is too low or the buffer 
capacity is reached. As a result of this 2 step process, various sized DNA structures (consisting 
of concatenated inverted repeats of the target sequence) are formed. Because LAMP recognizes 
the target by six distinct sequences initially and by four distinct sequences afterwards, it is 
expected to amplify the target sequence with high selectivity. Furthermore, an accelerated 
LAMP procedure has been developed that employs two additional primers (LoopF and LoopB) 
for enhanced specificity and reaction efficiency [52]. 
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2.2.1. Key features  
The key features of LAMP reaction are as follows: 
- Isothermal:  LAMP does not require complicated thermal cyclers as the ones used for 
PCR for carrying out reactions.  
- Simple visual assessment of amplification: using turbidity or by addition of fluorescent 
or chromogenic reagents (like SYBR green intercalating dye), 
- Low detection limit: As few as 1 copy per reaction have been detected using LAMP 
assays. This is similar to PCR 
- High specificity: 4-6 primers target 6-8 regions in the target nucleic acid, reducing the 
chances for non-specific amplification.   
- Robustness: It requires minimal sample preparation such as purification steps. LAMP 
reactions have been shown to be specific and perform efficiently in the presence of 
PCR inhibitors like cellular debris, urine, stool etc. 
- Assay time: Lamp assays can be give detection results in as little as 10min - 15min. It 
depends on the initial template concentration and using LF / LB loop primers is possible 
to decrease a long detection time.  
- Amplification yield: While PCR yields 10ug/mL of DNA copies, LAMP produces 500 
ug/mL allowing detection through turbidity measurements. Overall LAMP has been 
proposed as an ideal technique for nucleic acid amplification for point-of-care devices 
since it has less demanding equipment and has better sensitivity and specificity over 
PCR and other methods.  
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3. Materials and Methods 
In this section, we present the materials and methods used in the characterization of LAMP assays 
and development of the portable smartphone-based infectious disease platform. The setup 
composed of three main components:  
1. LAMP assays for the specific detection of nucleic acid targets  
2. A microfluidic chip that served as the reaction chambers for our parallel, multiplexed 
detection of the nucleic acid targets  
3. Smartphone-based reader for the fluorescence-based detection of LAMP amplification.  
3.1. LAMP assay development 
For this work, we developed four LAMP assays for the specific detection of four equine respiratory 
pathogen targets. The assays were first developed and characterized off-chip in pcr tubes in a 
commercial thermocycler. The assay development can be categorized in three broad categories:  
1. Primer design – novel primer sets were designed for each of the four targets  
2. Characterization of LAMP primers – the developed LAMP primers were tested for 
specificity with the target of interest. Cross- reactivity tests were carried out to perform the 
most specific primer sets  
3. Limit of detection tests – lower limits of detection for each of the primer sets were 
determined so as to ensure that our assays could detect targets in the clinically relevant 
concentration of these pathogens.  
4. Translation of assays to on-chip – the steps 2 and 3 were directly translated and tested on-
chip to validate our smartphone-based detection system for the multiplexed detection of 4 
of the targets.  
10 
 
Gold standard qPCR assays were also designed for each of the four targets and compared with the 
LAMP assay. Figure 3.1 shows a flowchart outlining the assay development starting from the 
design of primer to on-chip assay translation.  
Figure 3.1. Flowchart for primer design and assay   
 
We chose Streptococcus Equi (ATCC® 9528™), Streptococcus Zooepidemicus 
(ATCC® 39920™), Equine Herpesvirus-1 (USDA 040-EDV), and Equine Herpesvirus-4 (USDA 
044-EDV) as the pathogens of interest due to their widespread virulence among horse populations. 
The S. Equi and S. Zoo bacteria were received in lyophilized form and were propagated in bovine-
brain heart infusion medium (Sigma Aldrich) for a period of 16 hours to obtain a carrying 
concentration of 1×108 colony forming units (CFU)/mL. 500uL of glycerol stocks were prepared 
from this concentration and are stored at -80 °C until needed for experiments. The Equine 
Herpesvirus-1 and Equine Herpesvirus-4 stocks are obtained suspended in culture medium and 
were aliquoted into smaller volumes and also stored at -80 °C until needed. DNA from all the 
pathogens were extracted via a standard heat-lysing protocol. Heat lysis was chosen as the method 
of DNA extraction for this work due to the simple protocol, short processing time, and low cost. 
Briefly, 1 mL of culture-grown equine pathogens is centrifuged at 12,000 rpm for 1 minute. The 
supernatant is discarded and the cells are suspended in 200uL of nuclease free water. The cells are 
then heat-lysed at 95 ˚C for 5 minutes, followed by 3 minutes of centrifugation at 12,000 rpm. The 
supernatant containing the extracted DNA was retrieved and ready for immediate use or is stored 
at -80 ˚ C until use. This protocol can be easily adapted for use in field testing with a simple heating 
block. LAMP assays using unfiltered sample material can be performed without loss of specificity. 
The extracted DNA is quantified using PCR standard curves that were established using synthetic 
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targets. The PCR standard curves are shown in Figure 4.1..PCR reactions were carried out using 
the Promega GoTaq Green MasterMix according to the manufacturer’s instructions.  
Novel LAMP primers were designed for S. Equi and S. Zoo, targeting the seM and sorD genes 
respectively. The target sequence for S. Equi was obtained from the NCBI database using 
GenBank AJ249868.1 and U73162.1. The target sequences for S. Zoo were also obtained from the 
NCBI database using GenBank CP002904.1, NC_011134.1, and FM204884.1. LAMP primers 
were designed using Primerexplorerv4 (https://primerexplorer.jp/e/). LAMP primers for EHV-1 
and EHV-4 were utilized from the sequences reported from literature. All LAMP primers were 
synthesized by Integrated DNA Technologies (IDT DNA) and are listed in Table S2. Briefly, each 
primer mix consists of 0.2 µM of F3 and B3, 1.6 µM of FIP and BIP, and 0.8 µM of Loop F and 
Loop B primers.  
A 25 µL LAMP reaction mix were prepared containing the following: 3.5 µL of 10mM dNTPs 
(New England Biolabs), 2.5 µL of 10X Isothermal Amplification Buffer (New England Biolabs), 
2 µL of 5M Betaine (Sigma Aldrich), 1.5uL of 100mM Magnesium Sulfate Solution (New England 
Biolabs), 2 µL of primer mix, 2 µL of 8000units/mL Bst 2.0 Warmstart DNA Polymerase (New 
England Biolabs), 1.25 µL of 20X Evagreen Dye (Biotium), 2.25 µL of DEPC-treated water 
(Invitrogen), and 8 µL of the template DNA. The LAMP reactions are validated on a benchtop 
thermocycler (Eppendorf Realplex Thermocycler) at 65 °C for 40 minutes and terminated by 
heating at 85 °C for 5 minutes. For the off-chip experiments performed on thermocycler, the 25 
µL reaction mix is divided into three equal parts (~8 µL) for triplicate repetition. Ten-fold serial 
dilutions of the extracted DNA are carried out in DEPC-treated water to determine the working 
range of our LAMP assays. For on-chip experiments, 15 µL of the reaction mix without primers 
is used for injection.   
The specificity of the LAMP primers were validated by testing each of the 4 targets each of the 4 
primers. The results of the specificity test are shown and summarized in Figure 4.4 and Table 4.1. 
respectively. Both the specificity and limits of detection tests were performed with both plasmid 
targets and nucleic acid extracted directly from the pathogen.  
The primer sequences (PCR and LAMP) designed for these assays are listed below:  
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Table 3.1. Primer sets used in this study  
Pathogens LAMP assay primer sequences Sequence 
Streptococcus 
Equi 
 
F3: AAA ACT AAG TGC CGG TGC2  
B3: AAA ACT AAG TGC CGG TGC2  
FIP: TAC GAC TAA CCT CAG AGT TCG CTA TCA GTA TTA GTT GCA 
ACA AGT G 
BIP: CGA CTC CAA GAT TAT CGC GTG ATT GAA CTT TTT GGG CTG 
ATG A 
Loop F: ACA GTT GTC CCT CCC AAC A  
Loop B: GCG ATA TAG CCA TAA GTG GAG ATG 
F: CGG ATA CGG TGA TGT TAA AGA 
R: TTC CTT CCT CAA AGC CAG A 
Streptococcus 
Zooepidemicus 
F3: AAA GAC CCT CAT GGG AAA T 
B3: CCT TAG TTG CCG CAT AGG 
FIP: CCT GAC TAA CCA AAT ATA AGC CCT TGA GCT GGA CGA TAA 
GAC CT 
BIP: TGT TGG ACG TAT TTT GGT TGC TCT TCT GAG CCT TCT AAA 
CCT G  
Loop B: GGT GTC ATT ATT AAC ATG GCC TCT 
F: CAG CAT TCC TGC TGA CAT TCG TCA GG 
R: CTG ACC AGC CTT ATT CAC AAC CAG CC 
Herpesvirus 4 F3: CAA GAC GTA ACA ACG GGA GT  
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 B3: CGC AAG TAA CGG CGA TGA 
FIP: CGC TCT CCG TTT TCT TCC GAC AAG CCA CCC AGG ATT AGT 
CAA 
BIP: TTA CCC GGA CGG CCT TCC AAC GGG CAT GTC CTC AAC AA 
Loop F: GCC TGC TAC TCC GCA TG 
Loop B: AGC GTT GTA TAT GAT GCA TCC CCT 
F: GAC CTC TCC GTT CAC CCA AG 
R: TCC GTT TTC TTC CGA CAG GG 
Herpesvirus 1 
 
F3: GGC ATT TAC GTG TGG TCC TT 
B3: TCG CGG GCA TTT TTG TAC C 
FIP: GTC CAG CAA CGG TGC GTT GTG GCA CGC TCG TTA ACA GT 
BIP: CGA GCC TGA AGG GGG AAA ACT GGA GCT GTG TGG AAA 
GTA GC 
Loop F: AGG TTG AGA CGG TAA CGC TG 
Loop B: CAC GTG CGT CGT CGC AA 
F: GCG CCA GCT GTT TAA CCT TC 
R: CGG GCA TTT TTG TAC CAC CG 
Table 3.1. continued 
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3.2. Chip fabrication 
The fabrication for chip fabrication was developed by Weili Chen from Professor Brian 
Cunningham’s group. The protocol is illustrated in Figure 3.2. Briefly, an oxidized silicon 
microfluidic chip contained ten parallel lanes with a common sample injection inlet. Primers 
specific to the targets of interest was pre-dried in each of the lanes, and LAMP reaction mix 
(prepared off-chip) without the primers was manually injected into the sample inlet. The chip 
size was the same as a standard SIM card (25mm*15mm). Each of the lanes were 1mm in 
length, 500um in width, and 200um in depth, thereby allowing a total of 1uL of reaction mix 
per well. The fabrication procedure for the chip is illustrated in Figure 3.2. A single-side polish 
4” Silicon wafer was used as the substrate. The wafer was cleaned using standard degreasing 
protocol and a positive tone photoresist was spin-coated to form a 4.5um thick covering layer. 
A soft bake of 2 mins at 60C followed by 1min at 110C was performed. The photoresist was 
then exposed with an i-line (365nm) mask aligner (EVG 620) at a exposure dose of 180 J/cm2. 
The exposed regions of the positive tone photoresists were weakened upon exposure and were 
subsequently removed by immersing the wafer in a 1:4 ratio of AZ developer in deionized 
water. 4 minutes incubation was sufficient to remove all the photoresist in the exposed regions. 
The developer activity was quenched by holding wafer against running deionized water. A 
hard-bake at 110C for 1 minute was then performed to harden the remaining unexposed 
photoresist. Anisotropic etching of the exposed silicon was carried out using the Bosch process. 
In the Bosch process, alternating steps of SF6/O2 etching and C4F8 passivation was used to 
create 200 µm deep trenches in an inductively coupled plasma reactive ion etcher (ICP-RIE). 
The SEM image in Figure 3.2c shows vertical wells of 200um. The remaining photoresist after 
the Bosch process was stripped by using a combination of acetone degrease followed by O2 
descumming. The etched silicon wafer was then thermally oxidized at 1150C for 2 hours to 
form a 200nm film of SiO2. The wafer was then diced to form individual devices which were 
later used for downstream testing.  
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Figure 3.2: Ten-flow channel microfluidic chip for multiplexed LAMP detection. a) Schematic diagram 
of the fabrication process for the microfluidic chip. b) Photo of a fabricated chip taken with a US quarter. 
c)  Scanning electron microscope (SEM) image of the cross-section of the microfluidic channels. d) Primer 
deposition plan for the on-chip reactions.  
 
 
 
 
 
 
16 
 
 3.3. Chip preparation 
Before being used for the assays, the chips are treated with Piranha solution (a 3:1 mixture of 98% 
sulfuric acid (H2SO4) and 30% hydrogen peroxide (H2O2)), and rinsed with deionized water and 
blow-dried using nitrogen gas. The chips were stored at room temperature in a desiccator until use.  
The chip preparation can be divided into two categories:  
1. Primer deposition  
2. Chip sealing  
 
1. Chip sealing  
To be compatible with our workflow, our microfluidic chip must be able to  
a. Prevent evaporation of LAMP reaction mix when incubated with 65C  
b. Prevent cross-contamination between adjacent wells  
Mineral oil has been previously reported as the medium to prevent evaporation [55], but 
cannot be used in point-of-care systems. Towards this goal, we developed a simple protocol 
to seal the chips before incubating them at 65C for the LAMP reaction. The chips are 
covered with a transparent double-sided adhesive (DSA) (ARseal™ 90880, Adhesives 
Research). The sample inlet and the ten outlets are laser-cut so that the reaction mix can be 
flowed in. For reactions testing the limits of detection of primers on chip, 15uL of the 
complete reaction (with the primers) was flowed in. For experiments with dried primers 
(see section below), 15uL of the reaction mix without the primers were flowed in. The chip 
was degassed for 5 minutes in a desiccator to remove any air bubbles. The upper protective 
layer of the DSA was peeled off, and the chip was completely sealed with a glass coverslip. 
The binding is strong enough to prevent any leakage or cross-contamination during the 
reaction. This resulted in a amplification ready and completely sealed chip with ten 
independent reaction chambers.  
 
2. Primer deposition:  
For on-chip assays testing the limits of detection (Figure 4.5-4.8)reaction mix with the 
primer and target of interest was directly injected into the sample inlet. For reactions testing 
the primer specificity and co-infections [Figure 4.9] specific primers were deposited into 
each of the 10 lanes. Figure 3.2d illustrates the primer printing schematic. Lane #1 served 
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as a universal positive control. In this lane, 1uL of a high concentration of S.Zooep DNA 
(5e6 CFU/mL) was mixed in 1:1 ratio with 1uL of S.Zooep primer (diluted 1:20 ratio in 
nuclease-free water). 1uL of this solution was then pipetted pipetted at the outlet of lane 1. 
Since this lane contained both the target and primer sequence for S.Zooep, we expected 
this lane to amplify regardless of the sample present in sample solution. Hence, this lane 
served as a validation of the reaction components on-chip. Lane#2 served as the no-primer 
negative control. No primer sequences were printed on this lane, and no amplification 
reaction was expected from this lane. The primer printing configuration of the other lanes 
were as follows: Lanes 3,4 = S.Equi. Lane 5,6 = S.Zooep Lanes 7,8 – Equine Herpesvirus 
1 Lanes 9,10 = Equine Herpesvirus 4. Since the maximum reaction capacity of each lane 
was only 1uL, the primer mix was diluted in 1:20 ratio in nuclease-free water. 1 uL of the 
1:20 dilution of the appropriate primer mix was loaded at the outlets of each of the lanes. 
The liquid, upon pipetting, moved up the lane, but did not reach sample inlet. This allowed 
us to achieve uniform distribution of primers while preventing any primer cross-talk 
between the lanes. Due to the small volumes, the primers dry within a few minutes. The 
chips prepared with the dried primers can either be used immediately for testing or stored 
in a desiccator to be used for later experiments. The primers are hydrated when the reaction 
mix (without the primers) are injected into the sample inlet, and can then participate in the 
LAMP reaction. Amplification and a corresponding exponential increase in fluorescence 
is observed when the primer finds the specific template.  
 
Once the chip is ready for amplification, it is inserted into our custom-made cartridge (~ the size 
of a credit card). The cartridge allows the chip to inserted into our smartphone-based setup (Figure 
3.2b), and allows easy handling of the chip during transition. The cartridge was made from  
Polyoxymethylene (POM) due to the material’s low auto-fluorescence, low cost, ease of 
machining, and excellent dimensional stability. The chip was attached inside the card with 
adhesive, so the chip’s location within the imaging field of view was fixed inside the reader. 
Information about the chip and the assays were encoded in the quick response code (QR code). 
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3.4. Chip Imaging  
3.4.1. Fluorescence microscopy  
We used fluorescence microscopy to verify the on-chip assays on-chip before moving to our 
smartphone-based reader. Nikon Eclipse FN1 fluorescence microscope with a 2× objective and 
a Nikon 96311 B-2E/C FITC fluorescence filter was used to capture real-time images of the 
LAMP reaction. For fluorescence microscope-based real time LAMP reactions, a commercial 
heating stage (INSTECT mK1000) was used to incubate the chip at 65C. At a 2X objective, 
the field of view of the microscope allowed 6 out of the 10 wells to be imaged. The fluorescent 
image was used to construct amplification curves for the reactions tested. For limit-of-detection 
experiments, threshold times were determined for each of amplification curves, and a standard 
curve of threshold time vs input DNA concentration was constructed.  
 
3.4.2. Smartphone-based instrument 
The smartphone-based reader system was designed by Dr. Hojeong Yu from Professor Brian 
Cunningham’s group. The details about the instrumentation can be found in the manuscript 
http://pubs.acs.org/doi/pdf/10.1021/acs.analchem.7b02478The schematic of the reader is 
shown in Figure 3.3.  
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Figure 3.3: Smartphone-based instrument. a) Schematic diagram to show the internal structure of the 
cradle that integrates optical and electrical components used for smartphone fluorescence microscopy. The 
microfluidic chip, integrated in its card, is inserted into the cradle that incorporates a PTC heater to maintain 
a constant ~ 65 °C temperature. b) Photo of the smartphone-based instrument taken with the smartphone 
and chip card. A QR code label is printed on the chip card to provide information about the on-chip 
detection. 
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4. Results 
4.1. Off-chip characterization of the LAMP assay 
DNA from the culture-grown pathogenic source was extracted using the heat lysis protocol as 
described in the Materials and Methods section. The concentration of the extracted DNA was 
estimated using a PCR standard curve (Figure 4.1) constructed by using known amounts of target 
plasmid DNA in reaction. The limit of detection of the PCR assays was 1e5 copies/mL for all the 
targets. The LAMP limit of detection for the four assays were determined first in a tube-based 
reaction using a commercial thermocycler (Eppendorf MasterCycler RealPlex4). LAMP reactions 
were performed in tubes with ten-fold serial dilution of the DNA of interest. Figure 4.2(a-d) shows 
the baseline-subtracted amplification curves for the off-chip LAMP assay of S. Equi, S. Zoo, EHV-
1, and EHV-4 using purified DNA templates. Triplicate testing was done for each concentration 
by dividing a 25uL reaction into three 8uL final reactions. Threshold times from the amplification 
curves were calculated by determining the time taken for the curve to reach 20% of its maximum 
intensity. A good log-linear fit was obtained between the threshold times and the concentration of 
input DNA. The lower limit-of-detection was determined to be 5×104 copies/mL for S. Equi, 5×103 
copies/mL for S. Zoo and EHV-1, and 1×103 copies/mL for EHV-4. The limits of detection of our 
tube-based LAMP assays was superior compared to the PCR assays.  Figure 4.3 shows the same 
assay performed using plasmid DNA targets. A lower limit of detection of 1e5 copies/mL (starting) 
was obtained for each of the assays. To demonstrate the specificity of our LAMP assays, which is 
critical to the multiplexed on-chip detection, each of the four target DNA sequences were tested 
against non-specific primer sets (Figure 4.4). Specific template-primer amplification was observed 
for all four assays. The results are summarized in Table 4.1. 
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Figure 4.1: Off-chip PCR standard curves for the detection and quantification of equine respiratory 
infection pathogen DNA. The amplification curves and threshold time versus concentration relationship 
are plotted for a) S. Equi, b) S. Zoo, c) EHV-1, and d) EHV-4. 
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Figure 4.2: Off-chip characterization of the four LAMP assays developed for the detection of equine 
respiratory infection pathogen DNA. The amplification curves and threshold time versus concentration 
relationship are plotted for a) S. Equi, b) S. Zoo, c) EHV-1, and d) EHV-4. 
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Figure 4.3: Off-chip characterization of the four LAMP assays developed for the detection of equine 
respiratory infection pathogen using plasmid DNA templates. The amplification curves and threshold 
time versus concentration relationship are plotted for a) S. Equi, b) S. Zoo, c) EHV-1, and d) EHV-4. 
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Figure 4.4: Off-chip verification of assay specificity. The real-time reaction curves of a) the S. Equi 
DNA, b) S.Zoo DNA, c) EHV-1 DNA and d) EHV-4 DNA with all four primers and negative control 
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Table 4.1: Summary of the specificity of the four LAMP assays.  
 
 
4.2. On-chip characterization of the LAMP assay 
 
The experiments in this section were done in collaboration with Dr. Weili Chen and Ms. Fu Sun 
from Professor Cunningham’s group.  
4.2.1. On-chip limits of detection test 
Figures 4.5 – 4.8 summarizes the on-chip LOD tests for S. Zooep, S.Equi, EHV-1 and 
EHV-4 respectively. We observed an on-chip limit of detection of 5e4 copies/mL for S.Equi and 
S.Zooep, and 5e3 copies/mL for EHV-1 and EHV-4. No non-specific amplification (no template 
control) was observed in any of the assays for a period of 60 minutes reaction time.The 
concentration of the purified DNAs are within the clinically relevant ranges for the four pathogens  
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 Figure 4.5: On-chip characterization of the S. Zoo assay. The negative control a) and low DNA 
concentration test b) show no amplification within 60 minutes c) The limit of detection for the on-chip 
reaction is 5×104 copies/mL. The amplification reactions begin within 15 minutes for the high concentration 
tests at d) 5×105 copies/mL and e) 5×106 copies/mL. 
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Figure 4.6: On-chip characterization of the S. Equi assay detection limit. The limit of detection for the 
on-chip reaction is 5×104 copies/mL 
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Figure 4.7: On-chip characterization of EHV-1 assay detection limit. The limit of detection for the on-
chip reaction is 5×103 copies/mL 
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Figure 4.8: On-chip characterization of EHV-4 assay detection limit. The limit of detection for the on-
chip reaction is 5×103 copies/mL 
 
4.2.2. On-chip simultaneous detection tests 
We performed end point LAMP assays to demonstrate the primer specificity on-chip. End-
point images of the LAMP reactions were taken by our smartphone reader. (Figure 4.10). We pre-
printed the chips with target specific primers as described in the primer deposition section in the 
Materials and Methods section. Figure 4.10a shows the end-point LAMP fluorescent image as 
captured by our smartphone reader when the 5e7 copies/mL of S.Equi target DNA was introduced 
into the reaction. As evident from the figure, only lanes 1 (universal positive control, See Materials 
and Methods section), and lanes 3 and 4 (containing the S.Equi specific primer sets) showed an 
increased fluorescence above the pre-set intensity threshold. . The threshold value was designated 
as half of the intensity of the positive control as the value that is used to differentiate a positive 
test (target DNA present) from a negative test (target DNA not present). This demonstrated the 
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specific detection of the S,Equi target DNA in only the S.Equi specific primer printed lanes. 
Specific detection was observed when 5e6 copies/mL of S.Zooep DNA was used as the template 
(Figure 4.9b) where only lanes 1 (positive control), and lanes 5 & 6 (S.Zooep primers) showed an 
increased fluorescence above the threshold. The Figure 4.9c and Figure 4.9d show the results for 
detection of target DNA sequences from viral DNA targets EHV-1 and EHV-4 respectively. Both 
experiments showed clear evidence that the presence of target DNA can be specifically identified 
without inducing amplification in non-target lanes. The concentrations for the injected EHV-1 and 
EHV-4 DNAs were 5×106 copies/mL and 2×106 copies/mL respectively. Again, clear distinction 
between the positive and negative lanes were observed with the fluorescence intensity in the 
negative lanes being below the threshold.  
 
 
 
Figure 4.9 Continued 
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Figure 4.9 Continued 
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Figure 4.9 a-d: Experiments demonstrating one-at-a-time detection of target DNA sequences. 
Smartphone-captured images and intensities from each of the ten lanes on the fluorescence images are 
shown in a) for S. Equi detection, b) S. Zoo detection, c) EHV-1 detection and, d) EHV-4 detection. The 
LAMP reactions generate fluorescent output only in the positive control channel and the channels prepared 
with the specific primers. The presence of specific DNA sequences can be identified by the brightness of 
the lanes on the fluorescence images.  
 
 
 
 
 
 
 
 
 
Figure 4.9 Continued 
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5. Conclusion 
We demonstrate a compact, rapid, multiplexed, and inexpensive system for smartphone-based 
detection and identification of disease-specific nucleic acid sequences within a single-droplet test 
sample. The system utilizes a microfluidic approach for performing LAMP-based isothermal 
amplification of a multiplexed array of 1 to 10 pathogen-specific nucleic acid sequences, and uses 
a hand-held cradle that interfaces with the rear-facing camera of a conventional smartphone to 
capture the fluorescence images. The captured images are analyzed by a smartphone app and 
shared to a cloud-based database for the rapid reporting of the detection results. Four LAMP assays 
have been developed for the detection of the specific genes of four major pathogens that cause 
equine respiratory infectious diseases, including streptococcus equi, streptococcus zooepidemicus, 
equine herpesvirus types 1 and 4. As compared with the assays performed on a conventional 
laboratory thermocycler apparatus the detection sensitivity is not compromised using the 
microfluidic approach and the smartphone-based instrument. Importantly, the system is capable of 
detecting multiple nucleic acid targets at the same time, and thus is capable of identifying co-
infections of multiple pathogen strains. By generating a positive/negative determination of the 
presence of specific pathogens with integrated experimental controls and replicates, the mobile 
system can assist physicians in rapid point-of-care decision-making for treatment and quarantine 
response that is currently not possible with tests performed at central laboratory facilities. We 
believe this approach provides a mobile, simple and inexpensive capability for clinicians to 
perform infectious disease diagnostics, and it represents a significant stride towards a practical 
solution to the infectious disease diagnostics at resource-limited-settings.  
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